EP2134642A4 - Ciblage de tumeurs in vivo et détection spectroscopique avec marqueurs de nanoparticules raman améliorés en surface - Google Patents

Ciblage de tumeurs in vivo et détection spectroscopique avec marqueurs de nanoparticules raman améliorés en surface

Info

Publication number
EP2134642A4
EP2134642A4 EP08744924.5A EP08744924A EP2134642A4 EP 2134642 A4 EP2134642 A4 EP 2134642A4 EP 08744924 A EP08744924 A EP 08744924A EP 2134642 A4 EP2134642 A4 EP 2134642A4
Authority
EP
European Patent Office
Prior art keywords
enhanced raman
tumor targeting
vivo tumor
spectroscopic detection
nanoparticle tags
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP08744924.5A
Other languages
German (de)
English (en)
Other versions
EP2134642A1 (fr
EP2134642B1 (fr
Inventor
Ximei Quian
Dominic Ansari
Shuming Nie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Emory University
Original Assignee
Emory University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Emory University filed Critical Emory University
Publication of EP2134642A1 publication Critical patent/EP2134642A1/fr
Publication of EP2134642A4 publication Critical patent/EP2134642A4/fr
Application granted granted Critical
Publication of EP2134642B1 publication Critical patent/EP2134642B1/fr
Not-in-force legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
    • A61K49/0069—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
    • A61K49/0089—Particulate, powder, adsorbate, bead, sphere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0023—Di-or triarylmethane dye
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0032—Methine dyes, e.g. cyanine dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0041—Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
    • A61K49/0065—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the luminescent/fluorescent agent having itself a special physical form, e.g. gold nanoparticle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
    • A61K49/0069—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
    • A61K49/0089—Particulate, powder, adsorbate, bead, sphere
    • A61K49/0091—Microparticle, microcapsule, microbubble, microsphere, microbead, i.e. having a size or diameter higher or equal to 1 micrometer
    • A61K49/0093—Nanoparticle, nanocapsule, nanobubble, nanosphere, nanobead, i.e. having a size or diameter smaller than 1 micrometer, e.g. polymeric nanoparticle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/65—Raman scattering
    • G01N21/658—Raman scattering enhancement Raman, e.g. surface plasmons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2503/00—Evaluating a particular growth phase or type of persons or animals
    • A61B2503/40—Animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
    • A61B5/414—Evaluating particular organs or parts of the immune or lymphatic systems
    • A61B5/416—Evaluating particular organs or parts of the immune or lymphatic systems the spleen
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/70—Nanostructure
    • Y10S977/773—Nanoparticle, i.e. structure having three dimensions of 100 nm or less
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/70—Nanostructure
    • Y10S977/81—Of specified metal or metal alloy composition

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Nanotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
EP08744924.5A 2007-04-02 2008-04-02 Marqueurs de nanoparticules de SERS et procédée de détection spectroscopique de tumeurs Not-in-force EP2134642B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90965607P 2007-04-02 2007-04-02
PCT/US2008/059117 WO2008122035A1 (fr) 2007-04-02 2008-04-02 Ciblage de tumeurs in vivo et détection spectroscopique avec marqueurs de nanoparticules raman améliorés en surface

Publications (3)

Publication Number Publication Date
EP2134642A1 EP2134642A1 (fr) 2009-12-23
EP2134642A4 true EP2134642A4 (fr) 2014-05-21
EP2134642B1 EP2134642B1 (fr) 2016-02-24

Family

ID=39808725

Family Applications (1)

Application Number Title Priority Date Filing Date
EP08744924.5A Not-in-force EP2134642B1 (fr) 2007-04-02 2008-04-02 Marqueurs de nanoparticules de SERS et procédée de détection spectroscopique de tumeurs

Country Status (7)

Country Link
US (2) US20110165077A1 (fr)
EP (1) EP2134642B1 (fr)
JP (1) JP2010523983A (fr)
CN (1) CN101679022A (fr)
AU (1) AU2008232439B2 (fr)
CA (1) CA2682408A1 (fr)
WO (1) WO2008122035A1 (fr)

Families Citing this family (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009020680A2 (fr) * 2007-05-04 2009-02-12 Stanford University Imagerie moléculaire d'êtres vivants utilisant la spectroscopie raman et des nanoparticules raman étiquetées
US8722017B2 (en) 2008-07-10 2014-05-13 The Board Of Trustees Of The Leland Stanford Junior University Fluorescent magnetic nanoprobes, methods of making, and methods of use
EP2352766A4 (fr) * 2008-11-26 2012-06-13 Ca Nat Research Council Billes incluses dans un nanoagrégat conjuguées à des anticorps à un seul domaine
HUE031119T2 (en) * 2009-05-18 2017-06-28 Sicpa Holding Sa Particles for long wavelength SERS, a method for their production and a method for labeling the material
US20110077581A1 (en) * 2009-09-25 2011-03-31 Georgia Tech Research Corporation Targeted cellular delivery of nanoparticles
RS55757B1 (sr) * 2010-03-22 2017-07-31 Sicpa Holding Sa Sers nanomarkeri selektivni prema talasnoj dužini
EP2372347A1 (fr) * 2010-03-26 2011-10-05 Institut Pasteur Procédé pour augmenter le nombre de photons détectables pendant l'imagerie d'un marqueur biologique
WO2011132355A1 (fr) * 2010-04-20 2011-10-27 Panasonic Corporation Procédé de mesure d'une concentration d'une substance biogène contenue dans un corps vivant
US20130315834A1 (en) * 2010-09-24 2013-11-28 Nagamani Praveen Nanoprobe comprising gold colloid nanoparticles for multimodality optical imaging of cancer and targeted drug delivery for cancer
CN102004096B (zh) * 2010-09-28 2012-06-27 吉林大学 多环类芳烃的表面增强拉曼检测方法
EP2637553A2 (fr) 2010-11-12 2013-09-18 Emory University Systèmes et procédés additionnels fournissant une assistance anatomique en temps réel lors d'une procédure diagnostique ou thérapeutique
WO2012071523A1 (fr) * 2010-11-23 2012-05-31 Northwestern University Spectroscopie raman activée en surface et spatialement décalée combinée pour détection de biomolécule
EP2651569B1 (fr) * 2010-12-15 2017-03-08 Advanced Bionics AG Protection de surfaces en or implantées
US8697129B2 (en) * 2011-03-02 2014-04-15 Imra America, Inc. Stable colloidal gold nanoparticles with controllable surface modification and functionalization
US20180169279A1 (en) 2011-03-07 2018-06-21 The Trustees Of Columbia University In The City Of New York Apparatus, method and system for selectively affecting and/or killing a virus
JP6025756B2 (ja) 2011-03-07 2016-11-16 ザ トラスティーズ オブ コロンビア ユニバーシティ イン ザ シティ オブ ニューヨーク 殺菌装置、及び、殺菌装置の作動方法
WO2012165837A2 (fr) 2011-05-29 2012-12-06 한국화학연구원 Appareil de criblage à haute vitesse de plusieurs médicaments par analyse raman
US20140316255A1 (en) * 2011-09-02 2014-10-23 Ellis Garai Raman Imaging Devices and Methods of Molecular Imaging
WO2013166487A1 (fr) * 2012-05-04 2013-11-07 Yale University Nanosupports à pénétration élevée pour le traitement d'une maladie du snc
EP2880423B1 (fr) 2012-07-29 2021-02-24 Hewlett-Packard Development Company, L.P. Nanocapteur pour spectroscopie à diffusion
AU2013308472B2 (en) 2012-08-31 2017-05-25 Sloan-Kettering Institute For Cancer Research Particles, methods and uses thereof
CN102914646B (zh) * 2012-11-16 2014-08-20 湖南大学 基于表面等离子体耦合效应的均相多组分免疫分析方法
JP6465811B2 (ja) 2012-12-19 2019-02-06 スローン − ケタリング・インスティテュート・フォー・キャンサー・リサーチ 多様式の粒子、方法およびその使用
EP2951560B1 (fr) 2013-01-29 2019-03-20 Hewlett-Packard Development Company, L.P. Appareil doté d'éléments spectroscopiques exaltés en surface sur une surface externe
US9476833B2 (en) 2013-01-30 2016-10-25 Hewlett-Packard Devleopment Company, L.P. Forming 3-D nano-particle assemblies
US20140350534A1 (en) * 2013-02-20 2014-11-27 Sloan-Kettering Institute For Cancer Research Raman based ablation/resection systems and methods
US20160000329A1 (en) 2013-02-20 2016-01-07 Sloan-Kettering Institute For Cancer Research Wide field raman imaging apparatus and associated methods
CN103342999A (zh) * 2013-05-23 2013-10-09 厦门大学 一种生物功能化金纳米荧光探针及其制备方法
US9784737B2 (en) * 2013-10-15 2017-10-10 Board Of Trustees Of The University Of Arkansas Nanocomposites, methods of making same, and applications of same for multicolor surface enhanced Raman spectroscopy (SERS) detections
US9810687B2 (en) * 2013-10-15 2017-11-07 Board Of Trustees Of The University Of Arkansas Nanocomposites and methods of making same
US20150110882A1 (en) * 2013-10-18 2015-04-23 Japanese Foundation For Cancer Research Multifunctional metallic nanostructure and method for manufacturing the same
US11016089B2 (en) * 2014-02-17 2021-05-25 Board Of Trustees Of The University Of Arkansas Nanocomposites and nanoagents for detection and treatment of a target of interest and methods of making and using same
US10912947B2 (en) 2014-03-04 2021-02-09 Memorial Sloan Kettering Cancer Center Systems and methods for treatment of disease via application of mechanical force by controlled rotation of nanoparticles inside cells
CN104931476B (zh) * 2014-03-19 2019-05-28 中国科学院生态环境研究中心 一种多溴联苯醚的检测方法
CN103926246A (zh) * 2014-04-25 2014-07-16 厦门大学 一种用于疾病标志物或病原体检测的超高灵敏度探针及其制备方法和用途
CA2956210A1 (fr) 2014-07-28 2016-02-04 Memorial Sloan Kettering Cancer Center Nanoparticules de chalcogene metallique (metalloide) en tant que liants universels d'isotopes medicaux
US10588564B2 (en) * 2014-09-30 2020-03-17 Moein Health, LLC Method and kit for diagnosing and treating neoplastic tissue
KR101669954B1 (ko) * 2014-10-01 2016-10-27 강원대학교산학협력단 금 나노입자가 도입된 펩타이드 나노자기조립체의 제조 방법 및 이에 의해 제조된 금 나노입자가 도입된 펩타이드 나노자기조립체
WO2016086999A1 (fr) * 2014-12-04 2016-06-09 Medcom Advance, S.A Synthèse universelle en enceinte unique et pouvant être développée à grande échelle de nanoparticules codées dres
US10392598B2 (en) * 2015-06-19 2019-08-27 Emory University Methods of measuring cell purity for making quality control determinations and related compositions
EP3317035A1 (fr) 2015-07-01 2018-05-09 Memorial Sloan Kettering Cancer Center Particules anisotropes, leurs procédés et leurs utilisations
CN108431602B (zh) 2015-08-17 2022-04-08 瑞士菌分析股份公司 细菌快速试验
CN105108171B (zh) * 2015-09-24 2017-07-18 厦门大学 一种强拉曼信号的纳米颗粒的制备方法
CN105199095B (zh) * 2015-09-29 2017-05-03 南京邮电大学 一种基于巯基物质检测的两亲性分子探针及其合成方法
WO2017091640A1 (fr) 2015-11-24 2017-06-01 The Johns Hopkins University Rapporteurs de spectroscopie raman et procédés d'imagerie moléculaire de tissus in vivo
WO2017181000A1 (fr) * 2016-04-14 2017-10-19 Board Of Trustees Of The University Of Arkansas Nanocomposites et nano-agents pour la détection et le traitement d'une cible d'intérêt et leurs procédés de fabrication et d'utilisation
CN106093005A (zh) * 2016-06-06 2016-11-09 上海海洋大学 一种基于溶菌酶拉曼光谱成像的潜指纹高清识别方法
WO2017221981A1 (fr) * 2016-06-21 2017-12-28 日産化学工業株式会社 Procédé de détection simple utilisant la diffusion raman
CN107525794A (zh) * 2016-06-21 2017-12-29 天津大学 聚乙烯醇—纳米银复合材料在利用拉曼光谱检测结晶紫中的应用
CN109690294A (zh) * 2016-07-04 2019-04-26 塞尔图股份有限公司 用于测定转染的装置和方法
CN106248648B (zh) * 2016-07-10 2019-10-15 复旦大学 金为核银为壳的“拉曼静默区”基底及其制备方法与应用
DE102016215500B4 (de) * 2016-08-18 2020-02-20 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Sensorsystem zur Charakterisierung des Zustandes von in einem Kultivierungsgefäß enthaltenen Proben einer heterogenen Biomassestruktur
CN107837403B (zh) * 2016-09-21 2020-10-20 复旦大学 用于影像引导脑肿瘤切除的双模态纳米探针
CN106226285B (zh) * 2016-10-07 2019-10-15 复旦大学 一种金为核多巴胺为壳的“拉曼静默区”基底及其制备方法和应用
JP6841491B2 (ja) * 2016-10-21 2021-03-10 国立研究開発法人物質・材料研究機構 接着細胞内へのナノ粒子取り込み方法
EP3529205B1 (fr) 2016-10-21 2022-06-15 The United States of America, as represented by the Secretary, Department of Health and Human Services Nanotags moléculaires
US20200191720A1 (en) * 2017-07-19 2020-06-18 Hewlett-Packard Development Company, L.P. Protected nano-particle assemblies
US10935494B2 (en) 2017-07-19 2021-03-02 Hewlett-Packard Development Company, L.P. Matrix with plasmonically active nano structures
CN111344551B (zh) 2017-10-23 2021-07-20 美国政府(由卫生和人类服务部的部长所代表) 光谱散射流式细胞仪的光学配置方法
CN108072643A (zh) * 2017-12-28 2018-05-25 厦门大学 一种基于数字微流控技术和表面增强拉曼散射技术的靶标检测方法及系统
US11660378B2 (en) 2018-01-25 2023-05-30 Provincial Health Services Authority Endoscopic raman spectroscopy device
CN110270682A (zh) * 2018-03-15 2019-09-24 李吉光 一种纳米材料及其制造方法
CN109253998B (zh) * 2018-10-25 2021-09-28 珠海合晶科技发展有限公司 基于拉曼增强的金属-包裹物-抗体复合纳米粒子定量检测肿瘤标记物的方法
CN109406487B (zh) * 2018-10-29 2020-12-01 济南大学 检测阿尔茨海默症标志物的拉曼生物传感器及其制备方法
CN109682972A (zh) * 2018-12-19 2019-04-26 浙江卓运生物科技有限公司 一种检测乳腺癌肿瘤循环细胞的sers试剂
CN109668870B (zh) * 2019-01-24 2020-07-17 清华大学 基于表面增强拉曼检测溶液中铜离子浓度的方法
US20220099580A1 (en) * 2019-01-31 2022-03-31 Cytoveris Inc. Method and system for detecting cancerous tissue and tumor margin using raman spectroscopy
CN111624189B (zh) * 2019-02-27 2023-06-20 中国科学院宁波材料技术与工程研究所 一种检测癌细胞的表面增强拉曼散射磁性复合纳米材料
CN110231327A (zh) * 2019-03-11 2019-09-13 兰州大学 一种靶向识别胶原蛋白的多肽拉曼探针及其制备和成像方法
IL265914B (en) * 2019-04-08 2020-11-30 Convergent R N R Ltd System and method for optimization of radiotherapy treatments
WO2020216437A1 (fr) * 2019-04-23 2020-10-29 Espire Technologies Gmbh Dispositif et procédé de localisation ou d'identification de malignités
FR3097129B1 (fr) 2019-06-12 2021-06-11 Centre Nat Rech Scient Nanoparticules prefonctionnalisees a l’aide d’une monocouche auto-assemblee et leur methode de preparation
CN110542676A (zh) * 2019-09-26 2019-12-06 中山大学 一种可同时实现单细胞靶向药物递送和实时探测的全光学方法
US11453781B2 (en) 2019-12-17 2022-09-27 Tcl China Star Optoelectronics Technology Co., Ltd. Nano dye molecule, color filter, and display panel
CN111117302A (zh) * 2019-12-17 2020-05-08 Tcl华星光电技术有限公司 纳米染料分子、彩色滤光片及显示面板
EP4097455A4 (fr) * 2020-01-31 2024-03-20 Cytoveris Inc. Appareil et méthode de détection et de traitement de tissu cancéreux par spectroscopie raman et hyperthermie
CN111317831B (zh) * 2020-03-06 2022-02-25 中国人民解放军第四军医大学 一种用于川崎病冠脉炎ct成像的纳米探针及其制备方法和应用
JP7469107B2 (ja) 2020-03-31 2024-04-16 株式会社アルバック 金ナノ粒子の凝集体、金ナノ粒子分散液、放射線治療用増感剤及び金ナノ粒子分散液の製造方法
US20230305008A1 (en) * 2020-08-11 2023-09-28 Council Of Scientific & Industrial Research Sers-nanotag and diagnostic kit for detecting breast cancer biomarkers
CN114235773B (zh) * 2020-09-09 2024-02-09 南京大学 一种用于细胞膜修复过程动态监测的拉曼成像方法
CN113355394A (zh) * 2021-06-15 2021-09-07 杭州谱育科技发展有限公司 基于质谱技术的核酸检测方法
CN114767852A (zh) * 2022-04-18 2022-07-22 杭州师范大学 一种光控释放型中空金银纳米探针在用于制备肿瘤诊疗一体化制剂中的应用
CN115746091B (zh) * 2022-07-29 2024-10-01 胶原蛋白(武汉)生物科技有限公司 一种高稳定性的胶原蛋白靶向sers多肽探针及其在肝纤维化诊断中的应用
CN115531539B (zh) * 2022-09-19 2023-09-15 海南大学 一种近红外sers信号增强纳米探针及其制备方法和在一体化诊疗感染细菌中的应用

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050136258A1 (en) * 2003-12-22 2005-06-23 Shuming Nie Bioconjugated nanostructures, methods of fabrication thereof, and methods of use thereof
WO2005062741A2 (fr) * 2003-08-18 2005-07-14 Emory University Nanoparticuless composites actives a spectrometrie laser de l'effet raman exalte de surface, procedes de fabrication et d'utilisation associes
US20060054506A1 (en) * 1999-10-06 2006-03-16 Natan Michael J Surface enhanced spectrometry-active composite nanoparticles
US20060234248A1 (en) * 2003-12-29 2006-10-19 Lei Sun Composite organic inorganic nanoclusters

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5866336A (en) * 1996-07-16 1999-02-02 Oncor, Inc. Nucleic acid amplification oligonucleotides with molecular energy transfer labels and methods based thereon
AU2003213729A1 (en) * 2002-03-05 2003-09-22 Board Of Regents, The University Of Texas System Biospecific contrast agents
US20050064435A1 (en) * 2003-09-24 2005-03-24 Xing Su Programmable molecular barcodes
US7361410B2 (en) * 2003-12-29 2008-04-22 Intel Corporation External modification of composite organic inorganic nanoclusters comprising raman active organic compound
US20050191665A1 (en) * 2003-12-29 2005-09-01 Xing Su Composite organic-inorganic nanoclusters
KR100650522B1 (ko) * 2005-09-15 2006-11-27 재단법인서울대학교산학협력재단 표면증강 라만 산란법에 의해 표지된 마이크로 비드와유전전기영동력을 이용한 새로운 초고속 검색 방법

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060054506A1 (en) * 1999-10-06 2006-03-16 Natan Michael J Surface enhanced spectrometry-active composite nanoparticles
WO2005062741A2 (fr) * 2003-08-18 2005-07-14 Emory University Nanoparticuless composites actives a spectrometrie laser de l'effet raman exalte de surface, procedes de fabrication et d'utilisation associes
US20050136258A1 (en) * 2003-12-22 2005-06-23 Shuming Nie Bioconjugated nanostructures, methods of fabrication thereof, and methods of use thereof
US20060234248A1 (en) * 2003-12-29 2006-10-19 Lei Sun Composite organic inorganic nanoclusters

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
GAO X ET AL: "In vivo cancer targeting and imaging with semiconductir quantum dots", NATURE BIOTECHNOLOGY, NATURE PUBLISHING GROUP, NEW YORK, NY, US, vol. 22, no. 8, 18 July 2004 (2004-07-18), pages 969 - 976, XP002387133, ISSN: 1087-0156, DOI: 10.1038/NBT994 *
See also references of WO2008122035A1 *

Also Published As

Publication number Publication date
US20130149247A1 (en) 2013-06-13
CA2682408A1 (fr) 2008-10-09
CN101679022A (zh) 2010-03-24
WO2008122035A1 (fr) 2008-10-09
AU2008232439A1 (en) 2008-10-09
JP2010523983A (ja) 2010-07-15
AU2008232439B2 (en) 2014-10-09
EP2134642A1 (fr) 2009-12-23
US10137208B2 (en) 2018-11-27
US20110165077A1 (en) 2011-07-07
EP2134642B1 (fr) 2016-02-24

Similar Documents

Publication Publication Date Title
EP2134642A4 (fr) Ciblage de tumeurs in vivo et détection spectroscopique avec marqueurs de nanoparticules raman améliorés en surface
HRP20201015T8 (hr) Nova imunoterapija protiv nekoliko tumora, uključujući tumore neurona i mozga
EP2277049A4 (fr) Auto-anticorps dans la détection et le traitement du cancer
DK2268317T3 (da) Integrin-targeteringssubstanser og in vivo- og in vitro-billeddannelsesmetoder som anvender samme
DK2528505T3 (da) Apparat til ikke-invasiv in vivo-måling med raman-spektroskopi
ZA201101132B (en) Signatures and pcdeterminants associated with prostate cancer and methods of use thereof
EP2030003A4 (fr) Dispositif spectroscopique et système spectroscopique raman
EP2257810A4 (fr) Diagnostic moléculaire et classification de mélanomes malins
GB0803798D0 (en) Spectroscopic apparatus and methods
EP1950556A4 (fr) Substrat pour analyse destine a un usage dans une analyse spectroscopique raman et ensemble de substrat pour analyse
EP2225364A4 (fr) Classification d'un cancer et procédés d'utilisation
EP2295374A4 (fr) Nanoparticules de fullerène-silice à fluorescence améliorée, leur procédé de préparation et leur utilisation
GB201008981D0 (en) Methods and apparatus relating to surface-enhanced raman spectroscopy
EP2215961A4 (fr) Système d'acquisition d'informations in vivo et appareil pouvant être inséré in vivo
EP2183261A4 (fr) Dérivés d'acide polysialique, procédés de production, et utilisations pour améliorer la production et le ciblage d'antigènes de cancers
SG10201701286YA (en) Cancer detection methods and techniques
EP1946101A4 (fr) Detection d'apoptose in vivo
IL217565A0 (en) Methods and kits used in assessing cancer risk
GB0813352D0 (en) Cancer treatment and test
Popović Spectral line investigation in Extragalactic Objects
Reissner Methodological appendix
GB0712424D0 (en) Fluorescent dyes and complexes
GB0906881D0 (en) Barcode calorie calculator and personal calorie organiser
GB0707989D0 (en) IED and Exdplosively formed penetrator counter measures
AU322930S (en) Bicycle carrier

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20091001

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

RIN1 Information on inventor provided before grant (corrected)

Inventor name: ANSARI, DOMINIC

Inventor name: NIE, SHUMING

Inventor name: QUIAN, XIMEI

RIN1 Information on inventor provided before grant (corrected)

Inventor name: NIE, SHUMING

Inventor name: QUIAN, XIMEI

Inventor name: ANSARI, DOMINIC

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20140423

RIC1 Information provided on ipc code assigned before grant

Ipc: B82Y 5/00 20110101ALI20140415BHEP

Ipc: B82B 1/00 20060101AFI20140415BHEP

Ipc: G01N 21/65 20060101ALI20140415BHEP

Ipc: A61K 49/00 20060101ALI20140415BHEP

Ipc: A61B 5/00 20060101ALI20140415BHEP

Ipc: C12Q 1/68 20060101ALI20140415BHEP

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

INTG Intention to grant announced

Effective date: 20150902

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 776594

Country of ref document: AT

Kind code of ref document: T

Effective date: 20160315

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

RIN2 Information on inventor provided after grant (corrected)

Inventor name: QIAN, XIMEI

Inventor name: NIE, SHUMING

Inventor name: ANSARI, DOMINIC

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602008042499

Country of ref document: DE

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20160224

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 776594

Country of ref document: AT

Kind code of ref document: T

Effective date: 20160224

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160224

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160224

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160224

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160524

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160525

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160224

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160224

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160224

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160624

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20160430

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160224

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160224

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160224

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160224

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160224

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160224

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602008042499

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160224

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160224

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160224

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160402

Ref country code: BE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160224

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

Effective date: 20161230

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20160430

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20160430

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20160502

26N No opposition filed

Effective date: 20161125

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160524

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160224

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20160402

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20170427

Year of fee payment: 10

Ref country code: GB

Payment date: 20170427

Year of fee payment: 10

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20080402

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160224

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160224

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160224

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160224

Ref country code: MT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20160430

REG Reference to a national code

Ref country code: DE

Ref legal event code: R119

Ref document number: 602008042499

Country of ref document: DE

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20180402

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20181101

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180402